HCW Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:HCWB Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
20 Feb 24	BuyUS$1,065,000	Rebecca Byam	Individual	760,714	US$1.40
20 Feb 24	BuyUS$100,001	Lee Flowers	Individual	71,429	US$1.40
20 Feb 24	BuyUS$50,001	Lisa Giles	Individual	35,715	US$1.40
20 Feb 24	BuyUS$50,000	Richard Greene	Individual	35,714	US$1.40
20 Feb 24	BuyUS$1,035,003	Hing Wong	Individual	739,288	US$1.40
20 Feb 24	BuyUS$200,001	Scott Garrett	Individual	142,858	US$1.40
14 Sep 23	BuyUS$3,256	Gary Winer	Individual	1,587	US$2.08
14 Sep 23	BuyUS$3,741	Hing Wong	Individual	1,800	US$2.08
13 Sep 23	BuyUS$10,490	Rebecca Byam	Individual	5,000	US$2.10
12 Sep 23	BuyUS$1,230	Gary Winer	Individual	600	US$2.05
12 Sep 23	BuyUS$20,715	Rebecca Byam	Individual	10,000	US$2.09
08 Sep 23	BuyUS$19,853	Rebecca Byam	Individual	10,000	US$2.02
07 Sep 23	BuyUS$823	Gary Winer	Individual	463	US$1.95
06 Sep 23	BuyUS$9,749	Rebecca Byam	Individual	5,000	US$1.95
09 Jun 23	BuyUS$41,286	Rebecca Byam	Individual	20,000	US$2.06
08 Jun 23	BuyUS$51,020	Rebecca Byam	Individual	24,696	US$2.21
08 Jun 23	BuyUS$21,574	Lee Flowers	Individual	10,000	US$2.16
06 Jun 23	BuyUS$68,123	Rebecca Byam	Individual	39,062	US$1.82
02 Jun 23	BuyUS$2,522	Hing Wong	Individual	1,600	US$1.62
31 May 23	BuyUS$2,043	Gary Winer	Individual	1,350	US$1.52
31 May 23	BuyUS$7,750	Hing Wong	Individual	5,000	US$1.55
26 May 23	BuyUS$65,544	Rebecca Byam	Individual	40,000	US$1.66
24 May 23	BuyUS$91,082	Rebecca Byam	Individual	58,486	US$1.61

Insider Buying: HCWB insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.4%.

Top 25 shareholders own 55.63% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
42.5%	Hing Wong	16,054,156	US$26.2m	4.83%	no data
5.04%	Axone Capital	1,904,762	US$3.1m	0%	no data
3.65%	Rebecca Byam	1,381,909	US$2.3m	122%	no data
0.71%	Scott Garrett	267,858	US$436.6k	114%	no data
0.54%	The Vanguard Group, Inc.	205,142	US$334.4k	0.26%	no data
0.5%	Lee Flowers	190,238	US$310.1k	60.1%	no data
0.48%	HighTower Advisors, LLC	179,810	US$293.1k	-49.3%	no data
0.47%	Avantax Planning Partners, Inc.	179,541	US$292.7k	0%	0.01%
0.36%	Geode Capital Management, LLC	134,436	US$219.1k	1.46%	no data
0.35%	Cresset Asset Management, LLC	131,990	US$215.1k	0%	no data
0.22%	Bridgeway Capital Management, LLC	84,700	US$138.1k	2.54%	no data
0.2%	Peter Rhode	77,500	US$126.3k	59.8%	no data
0.12%	BlackRock, Inc.	47,158	US$76.9k	-1.18%	no data
0.12%	Richard Greene	44,125	US$71.9k	425%	no data
0.095%	Lisa Giles	35,815	US$58.4k	35,700%	no data
0.079%	AE Wealth Management, LLC	30,000	US$48.9k	0%	no data
0.06%	Two Sigma Investments, LP	22,640	US$36.9k	-0.88%	no data
0.057%	State Street Global Advisors, Inc.	21,446	US$35.0k	0%	no data
0.045%	Gary Winer	17,000	US$27.7k	0%	no data
0.027%	Citadel Advisors LLC	10,351	US$16.9k	0%	no data
0.027%	Northern Trust Global Investments	10,205	US$16.6k	0%	no data
0.015%	Tower Research Capital LLC	5,669	US$9.2k	21.6%	no data
0.0089%	Lord, Abbett & Co. LLC	3,382	US$5.5k	0%	no data
0.0026%	Focused Wealth Management, Inc.	1,000	US$1.6k	0%	no data
0.0017%	UBS Asset Management AG	635	US$1.0k	200%	no data